Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo
Authors:
Open Access
- 1 May 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (5) , 1143-1149
Abstract
OBJECTIVE—The purpose of this study was to compare an in vivo test of whole-body glycolysis, the deuterated-glucose disposal test (2H-GDT), with insulin sensitivity measured by the euglycemic-hyperinsulinemic glucose clamp and the steady-state plasma glucose (SSPG) test. RESEARCH DESIGN AND METHODS—The 2H-GDT consists of an oral glucose challenge containing deuterated glucose, followed by measurement of heavy water (2H2O) production, which represents whole-body glycolytic disposal of the glucose load. 2H2O production is corrected for ambient insulin concentration as an index of tissue insulin sensitivity. The 2H-GDT was compared with euglycemic-hyperinsulinemic glucose clamps in healthy lean subjects (n = 8) and subjects with the metabolic syndrome (n = 9) and with the SSPG test in overweight (n = 12) and obese (n = 6) subjects. RESULTS—A strong correlation with the clamp was observed for the 75-g and 30-g 2H-GDT (r = 0.95, P < 0.0001 and r = 0.88, P < 0.0001, respectively). The 2H-GDT and clamp studies revealed marked insulin resistance in subjects with metabolic syndrome compared with lean control subjects. The correlation with the clamp was maintained in each group (lean, r = 0.86, P < 0.01; metabolic syndrome, r = 0.81, P < 0.01) for the 75-g test. The 2H-GDT also correlated strongly with the SSPG test (r = −0.87, P < 0.0001) in overweight and obese subjects. CONCLUSIONS—The 2H-GDT, which measures whole-body glycolysis in humans in a quantitative manner, correlates highly with the euglycemic-hyperinsulinemic glucose clamp and the SSPG test. Impaired insulin-mediated whole-body glycolysis is a feature of insulin resistance, which provides a means of assessing insulin sensitivity in vivo.Keywords
This publication has 47 references indexed in Scilit:
- Use and Abuse of HOMA ModelingDiabetes Care, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Cellular mechanisms of insulin resistanceJournal of Clinical Investigation, 2000
- Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers.Diabetes Care, 2000
- Effects of infused glucose on glycogen metabolism in healthy humansClinical Physiology and Functional Imaging, 1996
- Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in ratsDiabetes, 1996
- Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approachDiabetes, 1989
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Metabolic basis of obesity and noninsulin‐dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1988
- Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetesJournal of Clinical Investigation, 1970